Patents Assigned to Pfizer
  • Cannabinoid receptor ligands and uses thereof
    Publication number: 20040157839
    Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventor: David A. Griffith
  • Methods for treating osteoarthritis using an estrogen agonist/antagonist
    Publication number: 20040157862
    Abstract: The present invention provides methods and kits for treating osteoarthritis using an estrogen agonist/antagonist.
    Type: Application
    Filed: January 22, 2004
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventor: Bruce H. Littman
  • Cannabinoid receptor ligands and uses thereof
    Publication number: 20040157838
    Abstract: Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventor: David A. Griffith
  • PPAR activators
    Publication number: 20040157885
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Application
    Filed: November 24, 2003
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventors: Scott W. Bagley, Thomas A. Brandt, Robert W. Dugger, William A. Hada, Cheryl M. Hayward, Zhengyu Liu
  • Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
    Publication number: 20040157824
    Abstract: This invention provides a compound of the formula: 1
    Type: Application
    Filed: February 3, 2004
    Publication date: August 12, 2004
    Applicant: Pfizer Inc.
    Inventors: Kazuo Ando, Tomoki Kato, Akiyoshi Kawai, Tomomi Nonomura
  • Process for the production of quinazolines
    Publication number: 20040158062
    Abstract: The present invention relates to a novel process for producing quinazoline compounds which are useful in therapy. More specifically, the compounds are useful in the treatment of benign prostatic hyperplasia.
    Type: Application
    Filed: February 9, 2004
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventors: Jens Bertil Ahman, Paul Blaise Hodgson, Sarah Jane Lewandowski, Robert Walton
  • Pharmaceutical compositions of semi-ordered drugs and polymers
    Publication number: 20040156905
    Abstract: A solid composition of a low-solubility drug and a concentration-enhancing polymer has a portion of the drug in a semi-ordered state.
    Type: Application
    Filed: August 5, 2003
    Publication date: August 12, 2004
    Applicant: Pfizer Inc.
    Inventors: Walter C. Babcock, William B. Caldwell, Marshall D. Crew, Dwayne T. Friesen, Ravi M. Shanker, Daniel T. Smithey
  • Novel methods involving the determination of activity of enzymes that use or produce prostaglandin endoperoxide H2
    Publication number: 20040152148
    Abstract: The present invention provides assays for determining the activity of an enzyme that uses or produces prostaglandin endoperoxide H2 (PGH2), methods of using the assays to screen for potential modulators of such enzymes, and kits for practice of the assays.
    Type: Application
    Filed: January 23, 2004
    Publication date: August 5, 2004
    Applicant: Pfizer Inc
    Inventor: Ralph H. Lambalot
  • Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
    Publication number: 20040152713
    Abstract: The present invention provides methods, pharmaceutical compositions and kits for treating joint pain and/or improving sleep using a SERM of formula (I): 1
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Applicant: Pfizer Inc.
    Inventor: Charles D. Petrie
  • Avermectin and praziquantel combination therapy
    Publication number: 20040151744
    Abstract: An antiparasitic combination therapy compising a combination of a 13-monosaccharide 5-oxime avermectin, such as selamectin, and praziquantel in a veterinarily acceptable carrier, diluent or adjuvant. Also provided is a method of treatment or prophylaxis of a parasitic infestation as well as a kit useful in the treatment or prophylaxis of a parasitic infestation of flea, heartworm or tapeworm in a mammal.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Applicant: Pfizer Inc
    Inventor: Bernard Frank Bishop
  • Thiazole compounds for treatment of neurodegenerative disorders
    Publication number: 20040152747
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: October 8, 2003
    Publication date: August 5, 2004
    Applicant: Pfizer Inc
    Inventors: Yuhpyng L. Chen, Michael L. Corman
  • N-(indole-2-carbonyl)-b-alaninamide crystal forms
    Publication number: 20040152758
    Abstract: The instant invention provides crystal forms of 5-chloro-N-[(1S,2R)-3-[3R,4S]-3,4-dihydroxy-1-pyrrolidinyl]-2-hydroxy-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide (I) 1
    Type: Application
    Filed: October 22, 2003
    Publication date: August 5, 2004
    Applicant: Pfizer Inc.
    Inventors: Douglas J. M. Allen, Frank R. Busch, Joseph F. Krzyzaniak, Zheng Jane Li, Susan L. Orrill, Peter R. Rose, Derek L. Tickner, Harry O. Tobiassen
  • Isothiazole derivatives useful as anticancer agents
    Publication number: 20040152691
    Abstract: The invention relates to compounds of the formula 1 1
    Type: Application
    Filed: July 24, 2003
    Publication date: August 5, 2004
    Applicant: Pfizer Inc
    Inventors: Blaise Lippa, Tricia Ann Kwan, Joel Morris, Susan D. LaGreca, Matthew David Wessel
  • Pharmaceutically active compounds
    Publication number: 20040152712
    Abstract: Compounds of the formula (1): 1
    Type: Application
    Filed: January 6, 2004
    Publication date: August 5, 2004
    Applicant: Pfizer Inc.
    Inventors: Mark Edward Bunnage, Keith Michael DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri, Stephen Derek Albert Street, Albert Shaw Wood
  • Pharmaceutically active compounds
    Patent number: 6770645
    Abstract: Compound of general formula I: wherein R1, R2, R3, R4, X, Y and R5 have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: August 3, 2004
    Assignee: Pfizer Inc.
    Inventors: Stephen Martin Denton, Mark Ian Kemp, Sandra Dora Newman, David James Rawson
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 6770778
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: August 3, 2004
    Assignee: Pfizer Inc
    Inventors: Stephen Douglas Barrett, Michael David Kaufman, Gordon William Rewcastle, Julie Ann Spicer
  • Drug delivery system
    Patent number: 6770288
    Abstract: A drug delivery device for delivering hormonal and other veterinary treatments intra-vaginally. A substance dispenser (21) is separate from the supporting device (20). The dispenser is in the form of drug impregnated gills or vanes (6, 7). In other aspects the drug may be dispensed by a micro-pump in the supporting device or the drug may be coated on the dispenser.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: August 3, 2004
    Assignee: Pfizer Products Inc.
    Inventor: Graham Francois Duirs
  • Anti-IgE vaccines
    Publication number: 20040146504
    Abstract: The present invention provides compositions and methods for the use of antigenic peptides derived from the Fc portion of the epsilon heavy chain of an IgE molecule as vaccines for the treatment and prevention of IgE-mediated allergic disorders. In particular, the invention provides compositions, methods for the treatment and prevention of IgE-mediated allergic disorders comprising an immunogenic amount of one or more antigenic peptides derived from the CH3 domain or junction of Ch-3/CH4 domain of an IgE molecule and methods for the evaluation of IgE mediated allergies in dogs.
    Type: Application
    Filed: January 5, 2004
    Publication date: July 29, 2004
    Applicants: Pfizer, Inc., Pfizer Products, Inc.
    Inventors: Mohamad A. Morsey, Michael G. Sheppard, David W. Wheeler
  • Liquid conjugates of solid pharmaceuticals
    Publication number: 20040147532
    Abstract: A liquid phase conjugate formed of a bioactive agent such as a drug compound, e.g. ziprasidone, and a liquid polymer of requisite functionality is disclosed.
    Type: Application
    Filed: October 24, 2003
    Publication date: July 29, 2004
    Applicant: Pfizer Inc
    Inventors: Shalaby W. Shalaby, Jaymin C. Shah
  • Combination chemotherapy
    Publication number: 20040147478
    Abstract: This invention relates to a method for treating cancer utilizing a combination of known oncolytic agents. Specifically, this invention relates to a method for treating cancer utilizing a combination of a MEK inhibitor and capecitabine.
    Type: Application
    Filed: November 14, 2003
    Publication date: July 29, 2004
    Applicant: Pfizer Inc.
    Inventor: Ronald Lynn Merriman